Table 2: Correlations between weight change, physiological effort and predicted VO2max in men with prostate cancer participating in a presurgical weight loss trial (n = 32).
Change in weight (kg) | Baseline HR @ Stage 1 | Baseline HR @ Stage 2 | Baseline VO2max | Baseline lean mass VO2max | Change in HR @ Stage 1 | Change in HR @ Stage 2 | Change in predicted VO2max | Change in lean mass VO2max | |
Change in weight (kg) | 1 | -0.260 | -0.380* | 0.406* | -0.039 | 0.393* | 0.576** | -0.241 | -0.058 |
Baseline HR @ Stage 1 | 1 | 0.943*** | -0.818*** | 0.375* | -0.370* | -0.282 | -0.009 | -0.063 | |
Baseline HR @ Stage 2 | 1 | -0.791*** | 0.503** | -0.396* | -0.453** | -0.033 | -0.107 | ||
Baseline Predicted VO2max | 1 | 0.136 | 0.356* | 0.341 | -0.166 | -0.101 | |||
Baseline lean mass VO2max | 1 | -0.134 | -0.251 | -0.264 | -0.294 | ||||
Change in HR @ Stage 1 | 1 | 0.826*** | -0.154 | -0.078 | |||||
Change in HR @ Stage 2 | 1 | -0.175 | -0.059 | ||||||
Change in predicted VO2max | 1 | 0.975** |
Stage 1: 3.22 km/hr, no incline; Stage 2: 3.22 km/hr, 4% incline; an = 31 due to no DEXA data; *p < 0.01; **p < 0.05; ***p < 0.001.